VIR in the 13F filings
Vir Biotechnology Inc · CUSIP 92764N102
- Quarter end
- 30 Sep 2024
- the date the book describes
- Filed
- 14 Nov 2024
- latest of these filings; the earliest 5 Nov 2024
- Managers listing it
- 5
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q2 2024 and Q3 2024; 5 listed it in both
- Shares listed
- 3,334,405
- combined, among listed positions
- Reported value
- $25m
- combined, at the quarter end
Among the 94 comparable managers: 4 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares was -1,335,500.
Managers listing VIR in Q3 2024
5 of 5 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Baillie Gifford & Co | 2,383,029 | $18m | under 0.1% | Trimmed | -1,538,213 | 5 Nov 2024 (the filing on sec.gov) |
| Hudson Bay Capital Management LP | 528,242 | $4.0m | under 0.1% | Added | +103,242 | 13 Nov 2024 (the filing on sec.gov) |
| PDT Partners LLC | 220,821 | $1.7m | 0.15% | Added | +56,494 | 14 Nov 2024 (the filing on sec.gov) |
| Winton Group Ltd | 130,965 | $981k | 0.07% | Added | +31,254 | 12 Nov 2024 (the filing on sec.gov) |
| Caxton Associates LLP | 71,348 | $534k | under 0.1% | Added | +11,723 | 14 Nov 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Hudson Bay Capital Management LPexisting position · 528,242 shares now+103,242
- PDT Partners LLCexisting position · 220,821 shares now+56,494
- Winton Group Ltdexisting position · 130,965 shares now+31,254
- Caxton Associates LLPexisting position · 71,348 shares now+11,723
Reductions
- Baillie Gifford & Coexisting position · 2,383,029 shares now-1,538,213
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2019 | 1 | $6.3m | n.a. | n.a. |
| Q1 2020 | 1 | $4.5m | n.a. | n.a. |
| Q2 2020 | 3 | $223m | n.a. | n.a. |
| Q3 2020 | 2 | $199m | n.a. | n.a. |
| Q4 2020 | 3 | $189m | n.a. | n.a. |
| Q1 2021 | 3 | $302m | n.a. | n.a. |
| Q2 2021 | 3 | $292m | n.a. | n.a. |
| Q3 2021 | 3 | $272m | n.a. | n.a. |
| Q4 2021 | 4 | $375m | n.a. | n.a. |
| Q1 2022 | 3 | $303m | n.a. | n.a. |
| Q2 2022 | 4 | $176m | n.a. | n.a. |
| Q3 2022 | 4 | $111m | n.a. | n.a. |
| Q4 2022 | 2 | $102m | n.a. | n.a. |
| Q1 2023 | 4 | $198m | n.a. | n.a. |
| Q2 2023 | 5 | $189m | n.a. | n.a. |
| Q3 2023 | 2 | $39m | n.a. | n.a. |
| Q4 2023 | 2 | $43m | 1 | 1 |
| Q1 2024 | 3 | $44m | 1 | 2 |
| Q2 2024 | 5 | $42m | 4 | 1 |
| Q3 2024 | 5 | $25m | 4 | 1 |
| Q4 2024 | 4 | $14m | 2 | 2 |
| Q1 2025 | 1 | $5.1m | 0 | 1 |
| Q2 2025 | 1 | $4.0m | 0 | 0 |
| Q4 2025 | 2 | $9.1m | 15 | 10 |
| Q1 2026 | 3 | $17m | 18 | 10 |
| Q2 2026 | 3 | $73m | 12 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
VIR and GILD →VIR and AMGN →VIR and ARGX →Choose a stock to compare with VIR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own VIR, latest filings →Back to the 13F Explorer →